MVZ Zentrum fuer ambulante Onkologie GmbH
- Address
- Paul-Ehrlich-Strasse 23, Waldhaeuser, 72076 Tübingen, Germany
MVZ Zentrum für ambulante Onkologie GmbH
MVZ Zentrum für ambulante Onkologie GmbH is a specialized outpatient oncology center dedicated to advancing cancer care through clinical research and innovative treatment approaches. The center demonstrates particular expertise in hematologic malignancies and myeloproliferative disorders, with a focus on personalized medicine strategies.
- Polycythemia vera treatment optimization and resistance prediction
- Artificial intelligence applications in hematologic oncology
- Hydroxyurea therapy management and monitoring
The center is actively engaged in prospective interventional studies that utilize machine learning and artificial intelligence to identify predictive risk factors for hydroxyurea resistance in patients with polycythemia vera. This cutting-edge approach combines traditional oncology expertise with modern predictive analytics to improve patient outcomes and personalize treatment strategies in myeloproliferative neoplasms.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MVZ Zentrum fuer ambulante Onkologie GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| HU-F-AIM - A prospective, interventional study to evaluate HU-resistance in polycythemia vera patients who meet predictive parameters identified in the machine learning project PV-AIM | Novartis Pharma GmbH | Phase III | Not Recruiting | Jul 2023 | Feb 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Hydroxycarbamide | 1 | Unknown | 2023-07-28 | 2023-07-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.